We analysed data from 64 patients with Wegener's granulomatosis to determine predictor variables of outcome. The mean period of observation after the diagnosis had been established was 3.2 (range 0.1-11.2) years. At the time of diagnosis, 15 (23%) patients had only local symptoms. The disease was generalized to multiple organs in 49 (77%) patients. Renal biopsies were obtained in 33 patients; 13 (39%) had extracapillary glomerulonephritis, which was the most common renal lesion. All but three patients received immunosuppressive therapy. At time of follow-up, 17 (27%) patients were in complete, and 26 (40%) in partial remission. We employed a Kaplan Meier analysis to identify predictor variables of outcome. Renal involvement, initial creatinine concentration, serum albumin or total protein concentration, leukocyte count and erythrocyturia proved to be predictor variables. These variables may be of value in guiding the intensity of treatment in patients with Wegener's granulomatosis.
Introduction
Wegener's granulomatosis (WG) is a form of necrotizing vasculitis characterized by granuloma formation in small and medium-sized vessels. Primarily involved are the upper and lower airways and the kidneys. Prior to the introduction of immunosuppressive therapy in the 1950s, the disease was regularly fatal in less than 5 months after diagnosis.' With the advent of immunosuppressive therapy, particularly the administration of cyclophosphamide and prednisolone, the outlook has improved considerably."2 Nevertheless, immunosuppressive therapy is not benign and side effects from treatment account for some of the mortality observed today in patients with WG.3 Thus, staged immunosuppressive treatment has been proposed. 4 An estimate of the prognosis in any given patient with WG would be helpful in planning treatment strategies, particularly in terms of aggressiveness and duration. We performed a retrospective analysis of 64 patients with WG to identify predictor variables of outcome. We were able to identify several variables that may assist in predicting the course of the disease.
Patients and methods
The records of 64 patients (37 men, 27 women, average age 48.5, range 17-81 years) who developed Wegener's granulomatosis, from 1971 to 1989, were obtained in this multicentre retrospective survey. The diagnosis was based on clinical, laboratory and histological criteria.',5
The patients were classified on the basis of their organ system manifestation at the time ofdiagnosis (ELK classification: E -ear, nose, throat; L -lung; K -kidney). 6 The outcome was assessed according to the criteria of remission as proposed by Fauci et al. ' The Kaplan -Meier technique7 was used to estimate survival. End point for survival analysis was the occurrence ofeither end-stage renal disease or death (defined as 'survival free of renal failure'). Survivors of subgroups were compared to one another by the log-rank test.8 The Bonferroni's correction,9 multiplication of P value by the number of tests performed, was employed to calculate the 'corrected' P value (significant at P < 0.05).
All data used in this study were evaluated at the time of diagnosis.
The following factors (n = 15) were examined for their prognostic relevance. Age> 50 years; (male) gender; involvement of the lung; involvement ofthe kidney; extracapillary glomerulonephritis; laboratory data -erythrocyte sedimentation rate>40 mm/h, serum protein concentration < 6.5 g/dl, serum albumin concentration < 3.5 g/dl, gammaglobulin ratio > 20%, haemoglobin < 12 g/dl, leukocyte count> 10,000/mm3, thrombocyte count> 400,000/mm3, serum creatinine concentration > 310 1mol/l, proteinuria>2 g/24 hours, erythrocyturia. Anti-neutrophil cytoplasmic antibodies (ANCA) could not be considered in this study, since they were first discovered in 1985. Our investigation was begun in 1971.
Results

Organ involvement
Grouping of patients according to the ELK classification is shown in Table I 
Laboratory data
All laboratory abnormalities in WG, with the exception of ANCA are non-specific; however, their presence and degree may have an impact on the prognosis of the disease. The incidence of pathologically altered laboratory findings is shown in Table III .
Treatment
All but three patients (95%) received immunosuppressive treatment. Forty-five (70%) patients were treated with prednisolone and cyclophosphamide (Fauci scheme), with 17 (27%) receiving methylprednisolone pulses at the beginning of therapy. Plasmapheresis was performed in eight (13%) patients with advanced disease. Azathioprine and prednisolone were the initial medication in 13 (20%) patients and prednisolone was used alone in three (5%) patients. Five patients who were initially treated with azathioprine were then converted to cyclophosphamide because of poor remission.
Outcome
Seventeen (27%) of the 64 patients died; 13 had complications of Wegener's granulomatosis or complications of immunosuppressive therapy, while four patients died of other causes (accident, cardiac disease, etc.). Twelve (19%) patients reached end-stage renal failure and five ofthem died. The (Figures 8 and 9 ).
Discussion
The present, retrospective report underscores the great prognostic significance of renal involvement in patients with WG. Not only involvement of the kidney itself, but also tests of renal function such as creatinine concentration and erythrocyturia proved to be significant indicators of outcome. Total serum protein and albumin concentrations, which were also related to outcome, are indirectly related to renal function. On the other hand, involvement Time [yearsl Figure 9 Prognostic relevance of patient gender to survival free of renal failure (P = 0. 1545, not significant).
more closely correlated to outcome than active glomerular lesions such as crescents and necrotizing granulomata. We did not have sufficient data to investigate this histological issue in detail directly. In addition, we could not confirm an important role for age in determining outcome. Such a result might be expected considering the independent effects of age on renal function. Other authors have reported such an influence.3 '14
Although gender did not prove to be a significant predictor of outcome in patients with WG, the relationship showed a trend in favour of women. Men had a greater prevalence of renal involvement than women. Further, isolated GN has been more commonly described in men than women. ' In an earlier study, we found that proteinuria and erythrocyturia were inversely associated with outcome of GN, irrespective of the cause.22 Both were associated with a poorer outcome in our WG patients, most likely because they indicated the presence of renal disease. The initial creatinine value at the time of diagnosis was also a significant prognostic indicator of survival free of renal failure, which further emphasizes the importance of renal involvement in terms of prognosis. On the basis of our findings, we conclude that early diagnosis, consideration of the variables we propose, and prompt therapy will improve prognosis; the improvement in serologic diagnosis of WG will facilitate that end.20'2' The presence of anti-neutrophil cytoplasmic antibodies and the ability of simple tests has greatly facilitated early diagnosis, as well as providing insight into possible mechanisms of the disease.'9 Most of the WG patients in the present report were diagnosed on clinical grounds years before this test became available.
The prognosis may be estimated according to clinical findings at the time of diagnosis. Balow2' suggested that the risk of end-stage renal disease would be 10% within 10 years in patients with any evidence ofrenal involvement. This value increased to 33% in patients with reduced renal function at the time of diagnosis, and to over 50% in patients with rapidly progressive glomerulonephritis. Our results corroborate that view. Involvement of the kidney to any degree is an important prognostic indicator of outcome. Outcome in patients with WG and a guide to subsequent management may be obtained from the serum creatinine concentration and the urinalysis. The presence of proteinuria, and the urinary sediment are pivotal clinical guidelines. Leukocytosis and decreased plasma protein values may also be helpful in determining which patients would be the most likely to warrant immunosuppressive therapy and to what degree.
